242 related articles for article (PubMed ID: 26108893)
1. Osteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation.
Weivoda MM; Ruan M; Pederson L; Hachfeld C; Davey RA; Zajac JD; Westendorf JJ; Khosla S; Oursler MJ
J Bone Miner Res; 2016 Jan; 31(1):76-85. PubMed ID: 26108893
[TBL] [Abstract][Full Text] [Related]
2. SMAD1/5 signaling in osteoclasts regulates bone formation via coupling factors.
Tasca A; Astleford K; Blixt NC; Jensen ED; Gopalakrishnan R; Mansky KC
PLoS One; 2018; 13(9):e0203404. PubMed ID: 30188920
[TBL] [Abstract][Full Text] [Related]
3. TGF-β induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts.
Ota K; Quint P; Ruan M; Pederson L; Westendorf JJ; Khosla S; Oursler MJ
Endocrinology; 2013 Oct; 154(10):3745-52. PubMed ID: 23861379
[TBL] [Abstract][Full Text] [Related]
4. Osteoblastic responses to TGF-beta during bone remodeling.
Erlebacher A; Filvaroff EH; Ye JQ; Derynck R
Mol Biol Cell; 1998 Jul; 9(7):1903-18. PubMed ID: 9658179
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Cell-Derived Juxtacrine Wnt1 Signaling Regulates Osteoblast Activity and Osteoclast Differentiation.
Wang F; Tarkkonen K; Nieminen-Pihala V; Nagano K; Majidi RA; Puolakkainen T; Rummukainen P; Lehto J; Roivainen A; Zhang FP; Mäkitie O; Baron R; Kiviranta R
J Bone Miner Res; 2019 Jun; 34(6):1129-1142. PubMed ID: 30690791
[TBL] [Abstract][Full Text] [Related]
6. TGF-β Signaling in Cranial Neural Crest Affects Late-Stage Mandibular Bone Resorption and Length.
Houchen CJ; Ghanem S; Kaartinen V; Bumann EE
bioRxiv; 2024 May; ():. PubMed ID: 38826301
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Wnt5a in osteoclasts results in bone loss through decreased bone formation.
Roberts JL; Liu G; Paglia DN; Kinter CW; Fernandes LM; Lorenzo J; Hansen MF; Arif A; Drissi H
Ann N Y Acad Sci; 2020 Mar; 1463(1):45-59. PubMed ID: 31919867
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
9. Gene Modification of Transforming Growth Factor β (TGF-β) and Interleukin 10 (IL-10) in Suppressing Mt Sonicate Induced Osteoclast Formation and Bone Absorption.
Yi L; Li Z; Jiang H; Cao Z; Liu J; Zhang X
Med Sci Monit; 2018 Jul; 24():5200-5207. PubMed ID: 30050032
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors.
Ota K; Quint P; Weivoda MM; Ruan M; Pederson L; Westendorf JJ; Khosla S; Oursler MJ
Bone; 2013 Nov; 57(1):68-75. PubMed ID: 23891907
[TBL] [Abstract][Full Text] [Related]
11. Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis.
Boyce BF; Li J; Yao Z; Xing L
Endocrinol Metab (Seoul); 2023 Oct; 38(5):504-521. PubMed ID: 37749800
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation.
Takeshita S; Fumoto T; Matsuoka K; Park KA; Aburatani H; Kato S; Ito M; Ikeda K
J Clin Invest; 2013 Sep; 123(9):3914-24. PubMed ID: 23908115
[TBL] [Abstract][Full Text] [Related]
13. E-selectin ligand 1 regulates bone remodeling by limiting bioactive TGF-β in the bone microenvironment.
Yang T; Grafe I; Bae Y; Chen S; Chen Y; Bertin TK; Jiang MM; Ambrose CG; Lee B
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7336-41. PubMed ID: 23589896
[TBL] [Abstract][Full Text] [Related]
14. Roles of Wnt signals in bone resorption during physiological and pathological states.
Maeda K; Takahashi N; Kobayashi Y
J Mol Med (Berl); 2013 Jan; 91(1):15-23. PubMed ID: 23111637
[TBL] [Abstract][Full Text] [Related]
15. Osteoclast synthesis and secretion and activation of latent transforming growth factor beta.
Oursler MJ
J Bone Miner Res; 1994 Apr; 9(4):443-52. PubMed ID: 8030431
[TBL] [Abstract][Full Text] [Related]
16. Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.
Mattson AM; Begun DL; Molstad DHH; Meyer MA; Oursler MJ; Westendorf JJ; Bradley EW
J Biol Chem; 2019 Aug; 294(31):11772-11784. PubMed ID: 31189651
[TBL] [Abstract][Full Text] [Related]
17. Regulation of bone metabolism by Wnt signals.
Kobayashi Y; Uehara S; Udagawa N; Takahashi N
J Biochem; 2016 Apr; 159(4):387-92. PubMed ID: 26711238
[TBL] [Abstract][Full Text] [Related]
18. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.
Kogawa M; Findlay DM; Anderson PH; Ormsby R; Vincent C; Morris HA; Atkins GJ
Endocrinology; 2010 Oct; 151(10):4613-25. PubMed ID: 20739402
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass.
Filvaroff E; Erlebacher A; Ye J; Gitelman SE; Lotz J; Heillman M; Derynck R
Development; 1999 Oct; 126(19):4267-79. PubMed ID: 10477295
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone.
Mohammad KS; Chen CG; Balooch G; Stebbins E; McKenna CR; Davis H; Niewolna M; Peng XH; Nguyen DH; Ionova-Martin SS; Bracey JW; Hogue WR; Wong DH; Ritchie RO; Suva LJ; Derynck R; Guise TA; Alliston T
PLoS One; 2009; 4(4):e5275. PubMed ID: 19357790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
